Home/Filings/4/0001628280-17-012316
4//SEC Filing

Cox Russell J. 4

Accession 0001628280-17-012316

CIK 0001232524other

Filed

Dec 12, 7:00 PM ET

Accepted

Dec 13, 5:53 PM ET

Size

14.8 KB

Accession

0001628280-17-012316

Insider Transaction Report

Form 4
Period: 2017-12-11
Cox Russell J.
SVP, Sales and Marketing
Transactions
  • Exercise/Conversion

    Ordinary Shares

    2017-12-11$8.23/sh+44,200$363,76696,263 total
  • Exercise/Conversion

    Ordinary Shares

    2017-12-11$46.83/sh+4,867$227,922101,130 total
  • Exercise/Conversion

    Incentive Stock Option (right to buy)

    2017-12-1144,2000 total
    Exercise: $8.23Exp: 2020-08-24Ordinary Shares (44,200 underlying)
  • Exercise/Conversion

    Ordinary Shares

    2017-12-11$59.13/sh+1,691$99,989102,821 total
  • Exercise/Conversion

    Incentive Stock Option (right to buy)

    2017-12-114,8670 total
    Exercise: $46.83Exp: 2022-08-08Ordinary Shares (4,867 underlying)
  • Exercise/Conversion

    Incentive Stock Option (right to buy)

    2017-12-111,6910 total
    Exercise: $59.13Exp: 2023-03-04Ordinary Shares (1,691 underlying)
Footnotes (4)
  • [F1]Includes 78 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on November 30, 2017.
  • [F2]This incentive stock option is part of an option award granted on August 25, 2010. The ordinary shares subject to the option award vested over 4 years from the vesting commencement date of July 21, 2010, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in 36 equal monthly installments thereafter and were fully vested as of July 21, 2014.
  • [F3]This incentive stock option is part of an option award granted on August 9, 2012. The ordinary shares subject to the option award vested over 4 years from the grant date with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter and were fully vested as of August 9, 2016.
  • [F4]This incentive stock option is part of an option award granted on March 5, 2013. The ordinary shares subject to the option award vested over 4 years from the grant date with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter and were fully vested as of March 5, 2017.

Issuer

Jazz Pharmaceuticals plc

CIK 0001232524

Entity typeother

Related Parties

1
  • filerCIK 0001512984

Filing Metadata

Form type
4
Filed
Dec 12, 7:00 PM ET
Accepted
Dec 13, 5:53 PM ET
Size
14.8 KB